TB Intensive Workshop

CE Accredited Live Activity
Date: April 8-11, 2025
Location:
Training Room
ICPH, 1st Floor West Wing
225 Warren Street
Newark, NJ 07103


COURSE DESCRIPTION & OVERALL GOAL
This workshop for clinicians provides comprehensive information on the application of principles for the diagnosis and treatment of TB, as well as the management of TB in special populations. The goal is to enhance healthcare provider knowledge and skills in the diagnosis, treatment, and management of TB, promote networking among providers in the Northeastern region and encourage providers to consult TB experts when needed. Topics include transmission and pathogenesis, diagnosis and treatment, drug resistance, TB-HIV co-infection, TB in children and adolescents, and key aspects of patient management. The format includes lectures, interactive discussions, and case studies.


AGENDA
Click here for the agenda.


WHO SHOULD ATTEND
The workshop is designed for physicians, nurses and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:

  • TB Programs
  • Health Departments
  • Hospitals
  • Correctional Facilities
  • Long Term Care Facilities
  • Immigrant & Refugee Health
  • Community Health Settings
  • College or University Health Services

WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.


OBJECTIVES
Upon completion of this workshop, participants should be better able to:

  • Interpret epidemiologic trends to better screen and treat groups who are at high-risk for tuberculosis.
  • Apply the latest advances for assessing risk, testing, and treating TB infection to prevent development of disease.
  • Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
  • List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.

COURSE REQUIREMENTS
This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at: http://www.cdc.gov/tb/education/corecurr/index.htm). In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 3 months of the course.

CONTINUING EDUCATION INFORMATION

Logo, company name  Description automatically generatedIn support of improving patient care, Rutgers Biomedical and Health      
Sciences is jointly accredited by the Accreditation Council for Continuing 
Medical Education (ACCME), the Accreditation Council for Pharmacy
Education (ACPE), and the American Nurses Credentialing Center
(ANCC), to provide continuing education for the healthcare team.

CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 22.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

CNE: This activity is awarded 22.25 ANCC contact hours. Nurses should only claim those contact hours actually spent participating in the activity.


DISCLOSURE POLICY

All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.


APPLICATION INFORMATION & FEE
This course requires an application process. Please click below to apply:
https://rutgers.ca1.qualtrics.com/jfe/form/SV_cBA5RrjBMJsIRyC


Please note that the fee for this course is $210 and payment must be received prior to the course. Breakfast and lunch will be provided.


Notification of acceptance and additional course information will be sent via email.


CANCELLATION AND REFUND INFORMATION
Please note that refunds will only be issued if registrants notify their cancellation by March 25. We will not be able to provide any refunds if registrants cancel after the deadline.
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary.


FUNDING DISCLOSURE

Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Priscilla Moreira at
pkm51@rutgers.edu.  

 

FACULTY


John Bernardo, MD
Professor of Medicine
Boston University School of Medicine

Kristina Feja, MD
Chief, Division of Pediatric Infectious Diseases
Saint Peters University Hospital

Jillian Knorr, MPH
Team Lead, Bureau of TB Control
New York City Department of Health and Mental Hygiene

Alfred Lardizabal, MD
Executive Director
Global Tuberculosis Institute

Imelda Lu
Patient Advocate

Navaneeth Narayanan, PharmDMPH
Clinical Assistant Professor
Rutgers University, Ernest Mario School of Pharmacy

Diana Nilsen, MD
Director of Medical Affairs, Bureau of TB Control
New York City Department of Health and Mental Hygiene

Amee Patrawalla, MD
Medical Director
Global Tuberculosis Institute

Marco Salerno, MPH
Deputy Director
Global Tuberculosis Institute

Chris Vinnard, MD
Clinical Development Leader
Bill & Melinda Gates Medical Research Institute

Mark Wolman, MPH
Consultant
Global Tuberculosis Institute

Patty Woods, RN, MSN
TB Nurse Consultant
Global Tuberculosis Institute

Ed Zuroweste, MD
Medical Consultant
Pennsylvania Department of Health

 

PLANNING COMMITTEE


Carolyn Bargman, RN-C, BSN
TB Nurse Consultant
Global Tuberculosis Institute

 
Anita Khilall, MPH - Activity Director
Program Director, Education & Training
Global Tuberculosis Institute

Alfred Lardizabal, MD
Executive Director
Global Tuberculosis Institute


Priscilla Moreira, MPH
Health Educator
Global Tuberculosis Institute

Shwata Suresh Kumar, MPH
Training and Consultant Specialist
Global Tuberculosis Institute